Thursday, March 23, 2023
Clinical Advances in
Read Overview
Supported by an independent educational grant from
Steering Committee Member Chair
Professor
Department of Medicine
Division of Pulmonary, Allergy,
and Critical Care Medicine
Professor
Department of Pediatrics
Penn State Hershey Allergy, Asthma
and Immunology
Penn State University
Hershey, Pennsylvania, United States
Honorary Consultant Clinical Immunologist
Immunology Department
Barts and The London NHS Trust
Leeds, United Kingdom
Clinical Professor of Internal Medicine
University of Texas
Southwestern Medical School
Dallas, Texas, United States
Professor
Department of Dermatology, Venereology,
and Allergology
Charité - Universitätsmedizin Berlin
Berlin, Germany
Professor of Dermatology
Director of Research
Department of Dermatology and Allergy
Head
Specialty Clinics for Urticaria, Mastocytosis, Pruritus
and Angioedema
Allergie-Centrum-Charité
Charité - Universitätsmedizin Berlin
Berlin, Germany
Director
US HAE Angioedema Center
Chief
Division of Rheumatology, Allergy,
and Immunology
Department of Medicine
University of California, San Diego
San Diego, California, United States
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: BioCryst; CSL Behring; GlaxoSmithKline; Grifols; Kabi; Regeneron; Spark; Takeda
Served as a speaker or a member of a speakers bureau for: BioCryst; CSL Behring; Grifols; Regeneron
Received grants for clinical research from: CSL Behring; GAK; GlaxoSmithKline; NioCryst; Regeneron; Takeda
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: BioCryst; CSL Behring; Intellia; Kalvista; Pharvaris; Takeda
Served as a speaker or a member of a speakers bureau for: BioCryst; CSL Behring; Takeda
Received grants for clinical research from: BioCryst; CSL Behring; Ionis; Intellia; Kalvista; Pharvaris; Takeda
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Accordant; BioCryst; Biomarin; CSL Behring; Express Scripts; Fresenius Kabi; Intellia; Kalvista; Magellan Optum; Pharming; Pharvaris; Shire; Takeda
HServed as a speaker or a member of a speakers bureau for: AstraZeneca; BioCryst; CSL Behring; GlaxoSmithKline; Grifols; Pharming; Regeneron; Sanofi; Shire; Takeda
Received grants for clinical research from: ALK; BioCryst; CSL Behring; Gossamer; Grifols; Ionis; Kalvista; Kedrion; Shire; Takeda; Therapure
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: BioCryst; CSL Behring; Dyax; Kalvista; Novartis; Octapharma; Pharming; Shire; Takeda
Served as a speaker or a member of a speakers bureau for: CSL Behring; Novartis; Shire; Takeda
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Allakos; Amgen; Aralez; ArgenX; AstraZeneca; Celldex; Centogene; CSL Behring; Genentech; GI Innovation; Innate Pharma; Kyowa Kirin; Leo Pharma; Lilly; Menarini; Moxie; Novartis; Regeneron; Roche; Sanofi; Third HarmonicBio; UCB; Uriach
Received grants for clinical research from: Allakos; Amgen; AstraZeneca; Centogene; CSL Behring; Genentech; GI Innovation; Innate Pharma; Leo Pharma; Lilly; Moxie; Novartis; Roche; Sanofi; Uriach
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: CSL Behring; Fresenius Kabi; Takeda